CEO Roundtable
New Fundraising Strategies and Case Studies in the Current Public Financing Environment
Thursday, October 20
8:15 a.m. - 9:15 a.m.
Marina
Where do life sciences companies turn for financing when public markets are soft? Join us as we take a look at the latest in PIPES (Private Investment in Public Equity Securities), late stage rounds with cross-over investors, and partnering/licensing strategies. Our panel of experts discussed when and why they favor various types of deals. Attendees listened to executives who found funding in a challenging market.
Moderator:
- Stephen C. Ferruolo, Shareholder, Heller Ehrman LLP
Panelists:
- Mark E. Epstein, Managing Director and Co-Head Private Equity Placements, Banc of America Securities LLC
- Rodney A. Ferguson, JD, PhD, Partner, JPMorgan Partners
- David Flores, President and Chief Executive Officer, BioCentury Publications, Inc.
- John F. Hamilton, Vice President, Finance and Chief Financial Officer, Depomed, Inc.
- Gregory P. Hanson, CMA, MBA, Vice President, Finance & CFO, Avanir Pharmaceuticals